EVIDENCE-BASED THERAPEUTIC ACTIVITY OF POMEGRANATE AND ITS ACTIVE CONSTITUENT ELLAGIC ACID

被引:0
|
作者
Mansoury, Manal M. S. [1 ]
机构
[1] King Abdulaziz Univ, Fac Home Econ, Dept Food & Nutr, Jeddah, Saudi Arabia
来源
PHARMACOPHORE | 2019年 / 10卷 / 01期
关键词
Pomegranate juice; ellagic acid; therapeutic activity; DOUBLE-BLIND; OXIDATIVE STRESS; ANTIOXIDANT STATUS; LIPID-PEROXIDATION; JUICE CONSUMPTION; DIABETIC-PATIENTS; EXTRACT; POLYPHENOLS; EFFICACY; IMPROVEMENT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Presently pomegranate is used in traditional medicine for its pharmacological properties. Consumption of fresh vegetables and fruits can improve the human health mainly because of their high contents of beneficial phytochemicals and other micronutrients. Pomegranate has multiple pharmacological activities including anti-inflammatory, antioxidant, and anticancer actions. Ellagic acid is a major compound of pomegranate which is naturally existing in many kinds. It has also been found in raspberries, blackberries, cranberries, strawberries, pecans, walnuts, green tea, pomegranates, and blueberries. Recently, numerous studies have proven the effectiveness of ellagic acid and pomegranate juice in the treatment of prostate cancer, diabetes, melasma, ultraviolet radiation-induced skin damage, endotoxemia, rheumatoid arthritis and osteoarthritis, cardiovascular diseases, blood pressure, hyperlipidemia, erectile dysfunction, dental disorders, diabetes, and idiopathic central precocious puberty. The therapeutic effect of ellagic acid and pomegranate juice could be due to the clinically evidenced antioxidant activities. In conclusion, ellagic acid may be used as a therapy or adjuvant therapy for the treatment of many illnesses. Copyright (c) 2013-All Rights Reserved-Pharmacophore.
引用
收藏
页码:30 / 36
页数:7
相关论文
共 50 条
  • [21] Evidence-based Therapeutic Drug Monitoring for Saquinavir
    Muret, Patrice
    Solas, Caroline
    THERAPIE, 2011, 66 (03): : 207 - 212
  • [22] The Therapeutic Alliance: An Evidence-Based Guide to Practice
    Norton, Christine Lynn
    CLINICAL SOCIAL WORK JOURNAL, 2013, 41 (02) : 218 - 219
  • [23] Evidence-based Therapeutic Drug Monitoring for Indinavir
    Barrail-Tran, Aurelie
    Taburet, Anne-Marie
    Poirier, Jean-Marie
    THERAPIE, 2011, 66 (03): : 239 - 246
  • [24] Current evidence-based therapeutic recommendations in narcolepsy
    Vasiliu, O.
    EUROPEAN PSYCHIATRY, 2020, 63 : S565 - S566
  • [25] Evidence-based practice and reviews of therapeutic touch
    O'Mathúna, DP
    JOURNAL OF NURSING SCHOLARSHIP, 2000, 32 (03) : 279 - 285
  • [26] Evidence-based Therapeutic Drug Monitoring of lopinavir
    Barrail-Tran, Aurelie
    Taburet, Anne-Marie
    Poirier, Jean-Marie
    THERAPIE, 2011, 66 (03): : 231 - 238
  • [27] The Therapeutic Alliance: An Evidence-Based Guide to Practice
    Heyland, Simon J. R.
    BRITISH JOURNAL OF PSYCHIATRY, 2011, 199 (05) : 434 - 435
  • [28] The therapeutic alliance: an evidence-based guide to practice
    Roddy, Jeannette
    COUNSELLING & PSYCHOTHERAPY RESEARCH, 2013, 13 (02): : 159 - +
  • [29] The therapeutic alliance: An evidence-based guide to practice
    Lambert, Michael J.
    PSYCHOTHERAPY RESEARCH, 2016, 26 (02) : 259 - 261
  • [30] Evidence-based Therapeutic Drug Monitoring for Efavirenz
    Solas, Caroline
    Gagnieu, Marie-Claude
    THERAPIE, 2011, 66 (03): : 197 - 205